COAG
Hemab Therapeutics Holdings, Inc. - Common Stock (COAG)
$63
About Hemab Therapeutics Holdings, Inc. - Common Stock (COAG)
Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company. It engages in developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience. The company was founded in 2020 and is headquartered in Cambridge, MA.
Details
Daily high
$33.88
Daily low
$31.32
Price at open
$32.16
52 Week High
$55.42
52 Week Low
$18.00
Market cap
1.5B
Dividend yield
-
Volume
132,812
Avg. volume
421,167
P/E ratio
--
Hemab Therapeutics Holdings, Inc. - Common Stock News
Details
Daily high
$33.88
Daily low
$31.32
Price at open
$32.16
52 Week High
$55.42
52 Week Low
$18.00
Market cap
1.5B
Dividend yield
-
Volume
132,812
Avg. volume
421,167
P/E ratio
--